Advertise with us
[January 29, 2014]
Worldwide Telemedicine Report: The Future is 'Now' for Moving Telemedicine into Mainstream Treatment
(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (
) has announced the addition of the "Worldwide Telemedicine Report: The Future is 'Now' for Moving Telemedicine into Mainstream Treatment" report to their offering.
The report, Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment was written to support both the biopharmaceutical and health care industries in understanding the use of telemedicine and preparing for the expected growth it will see in the coming years.
First used primarily for military and space applications, it has been becoming more widespread in use in recent years. There are three main types of telemedicine applications: store-and-forward, remote monitoring and interactive services.
Interest in telemedicine is growing globally, particularly in the fields of teleradiology, telepathology and teledermatology. Globally, cost is seen as the major barrier to telemedicine programs. In the US, telemedicine has been promoted as a way to serve rural populations, but in the next few years it is expected to spread to a much wider patient base.
A number of key challenges still need to be addressed for the use of telemedicine to become more widespread in the US. Licensing and reimbursement remain major hurdles to physician participation in telemedicine.
These challenges are being addressed at the state level, with an increasing number of state legislatures taking up the issues. There is also federal legislation being looked at by Congress. Issues of FDA Regulation and possible issues of taxation also need to be clarified to help promote wider use of telemedicine.
Key Reasons to Purchase - This comprehensive study can be used to compare the effectiveness of the different telemedicine applications - Companies can assess the impact of health care reform on telemedicine uptake now and in the future - Gain insights on the key challenges that exist to further expansion of telemedicine programs and how they can be overcome - Better evaluate the potential for telepharmacy programs, a key area of opportunity for the pharmaceutical industry - Utilize the insights from this study to analyze the barriers facing wider adoption of telemedicine Key Topics Covered: Executive Summary Chapter 1: Development of Telemedicine - Development of Telemedicine - Types of Telemedicine - Where Telemedicine is being Used - Expansion of Telemedicine Chapter 2: Key Challenges to Telemedicine - Licensing - Reimbursement - Legislation - Regulation - Taxation Chapter 3: Case Studies - Dermatology - Neurology - Diabetes - A UK Study - Heart Disease, Diabetes, and COPD - Elderly Patients - Intensive Care - Telepharmacy Chapter 4: The Outlook for Telemedicine - The Impact of Health Care Reform - New Technologies For more information visit
CONTACT: Research and Markets, Laura Wood, Senior Manager.
firstname.lastname@example.org Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals (
(c) 2014 M2 COMMUNICATIONS
Back To NFVZone's Homepage